Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumors.
Kang KM, Kang YN, Choi IB, Gu Y, Kawamura T, Toyoda Y, Nakao A · Medical gas research · 2011
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

The publication “Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumors.” is organized in H2HUBB under the research focus hydrogen water cancer supportive care study 2011. The publication is cited as Kang KM, Kang YN, Choi IB, Gu Y, Kawamura T, Toyoda Y, Nakao A, Medical gas research, 2011. This randomized controlled trial examined Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumors. The abstract describes Human participants; hydrogen delivered as hydrogen water; reported duration 6 weeks. The abstract reports: Daily consumption of hydrogen-rich water is a potentially novel, therapeutic strategy for improving QOL after radiation exposure. Consumption of hydrogen-rich water reduces the biological…. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen water cancer supportive care study 2011 overview
Cancer patients receiving radiotherapy often experience fatigue and impaired quality of life (QOL). Many side effects of radiotherapy are believed to be associated with… Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.
Study design and hydrogen intervention
Publication type: Randomized controlled trial. Evidence type: Human clinical evidence. Research model or population: Human participants. Randomized: Yes. Blinding: Unknown. Control status: Placebo-controlled.
Delivery method: Hydrogen water. Hydrogen concentration: 0.65 mM. Treatment duration: 6 weeks.
Reported findings and scientific interpretation
For this hydrogen water cancer supportive care study 2011, the study record reports the following: The abstract reports: Daily consumption of hydrogen-rich water is a potentially novel, therapeutic strategy for improving QOL after radiation exposure. Consumption of hydrogen-rich water reduces the biological…
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.